Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Credit NIAID-RML
Highlighted Sections
Clinical Management of Adults Summary
This section contains tables with the Panel’s recommendations for the therapeutic management of adults with COVID-19.
Clinical Spectrum
The Panel discusses some important limitations of using pulse oximetry to detect hypoxemia.
Ritonavir-Boosted Nirmatrelvir (Paxlovid)
Concerns about viral rebound and recurrence of COVID-19 symptoms should not be a reason to avoid the use of ritonavir-boosted nirmatrelvir.
Clinical Management of Children Summary
The tables in this section summarize the Panel’s recommendations for the therapeutic management of children with COVID-19 or MIS-C.
Pregnancy
This section includes updated data on the epidemiology of COVID-19 in pregnancy and the safety and efficacy of administering COVID-19 vaccines to pregnant people.
Paxlovid Drug-Drug Interactions
Several drugs have been added to this section, including Janus kinase inhibitors, anti-orthopoxvirus agents, and conjugated monoclonal antibody products.
Clinical Management of Adults Summary
This section contains tables with the Panel’s recommendations for the therapeutic management of adults with COVID-19.
Clinical Spectrum
The Panel discusses some important limitations of using pulse oximetry to detect hypoxemia.
Ritonavir-Boosted Nirmatrelvir (Paxlovid)
Concerns about viral rebound and recurrence of COVID-19 symptoms should not be a reason to avoid the use of ritonavir-boosted nirmatrelvir.
Clinical Management of Children Summary
The tables in this section summarize the Panel’s recommendations for the therapeutic management of children with COVID-19 or MIS-C.
Pregnancy
This section includes updated data on the epidemiology of COVID-19 in pregnancy and the safety and efficacy of administering COVID-19 vaccines to pregnant people.
Paxlovid Drug-Drug Interactions
Several drugs have been added to this section, including Janus kinase inhibitors, anti-orthopoxvirus agents, and conjugated monoclonal antibody products.
Clinical Management of Adults Summary
This section contains tables with the Panel’s recommendations for the therapeutic management of adults with COVID-19.
Clinical Spectrum
The Panel discusses some important limitations of using pulse oximetry to detect hypoxemia.
Ritonavir-Boosted Nirmatrelvir (Paxlovid)
Concerns about viral rebound and recurrence of COVID-19 symptoms should not be a reason to avoid the use of ritonavir-boosted nirmatrelvir.
Clinical Management of Children Summary
The tables in this section summarize the Panel’s recommendations for the therapeutic management of children with COVID-19 or MIS-C.
Pregnancy
This section includes updated data on the epidemiology of COVID-19 in pregnancy and the safety and efficacy of administering COVID-19 vaccines to pregnant people.
Paxlovid Drug-Drug Interactions
Several drugs have been added to this section, including Janus kinase inhibitors, anti-orthopoxvirus agents, and conjugated monoclonal antibody products.